Present status of nanoparticle research for treatment of tuberculosis.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques

Volumn 14, Issue 1, 2011, Pages 100-116

  Shegokar, Ranjita ^a   Al Shaal, Loaye ^b   Mitri, Khalil ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; NANOPARTICLE; TUBERCULOSTATIC AGENT;

ANIMAL; BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; REVIEW; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; MEDICATION ADHERENCE; MYCOBACTERIUM TUBERCULOSIS; NANOPARTICLES; TUBERCULOSIS; TUBERCULOSIS VACCINES;

MLCS; MLOWN;

EID: 79959287218     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3m59p     Document Type: Review

References (0)